ASH Group Meetings

Join Us At ASH 2024

Saturday, December 7th to Monday, December 9th, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ASH 2024 updates.

    Saturday, December 7th
    9:00 AM PT (12:00 PM ET) - Marc Braunstein
    • Multiple Myeloma, Lymphoma | Co-Director of Hematology-Oncology, NYU Grossman Long Island School of Medicine, NYU Langone Hospitals
    9:00 AM PT (12:00 PM ET) - Christine Duncan
    • Sickle Cell | Associate Professor of Pediatrics, Harvard Medical School
    10:00 AM PT (1:00 PM ET) - Ravi Vij
    • Multiple Myeloma | Professor of Medicine in Hematology-Oncology and Bone Marrow Transplantation, Washington University School of Medicine in St. Louis, MyCancerHaven
    10:00 AM PT (1:00 PM ET) - Ben Samelson-Jones
    • Hemophilia | Assistant Professor of Pediatrics, University of Pennsylvania
    11:00 AM PT (2:00 PM ET) - Andrew Yee
    • Multiple Myeloma | Clinical Director, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School
    11:00 AM PT (2:00 PM ET) - Kevin Kuo
    • Hemoglobinopathies | Associate Professor, Faculty of Medicine, University of Toronto
    12:00 PM PT (3:00 PM ET) - Joshua Brody
    • Lymphoma | Associate Professor, Division of Hematology and Oncology, Icahn School of Medicine, Mount Sinai
    12:00 PM PT (3:00 PM ET) - David Sallman
    • AML/MDS | Associate Member and Myeloid Section Head, H. Lee Moffitt Cancer Center and Research Institute
    1:00 PM PT (4:00 PM ET) - Sagar Patel
    • Leukemias, Lymphoma | Assistant Professor, Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah
    1:00 PM PT (4:00 PM ET) - Nirmish Shah
    • Sickle Cell | Assistant Professor of Medicine and Pediatrics, Duke University
    2:00 PM PT (5:00 PM ET) - Andrew Branagan
    • Multiple Myeloma, Lymphoma | Medical Director, Mass General Cancer Center at Nantucket Cottage Hospital
    3:00 PM PT (6:00 PM ET) - Michael Grunwald
    • Cell Therapy, MPNs, AML/MDS, GVHD | Chief of the Leukemia Division and Director of Transplantation and Cellular Therapy Program, Levine Cancer Institute at Atrium Health
    Sunday, December 8th
    9:00 AM PT (12:00 PM ET) - Farhad Ravandi
    • Leukemias | Professor of Medicine, The University of Texas MD Anderson Cancer Center
    9:00 AM PT (12:00 PM ET) - Ashwin Kishtagari
    • MPNs (Myelofibrosis, PV, ET), AML/MDS | Assistant Professor of Medicine in Hematology and Oncology, Vanderbilt University Medical Center
    10:00 AM PT (1:00 PM ET) - Ran Reshef
    • Cell Therapy | Professor of Medicine and Director of the Cellular Immunotherapy Program, Columbia University Medical Center
    11:00 AM PT (2:00 PM ET) - Jae Park
    • Cell Therapy, Leukemia | Chief of Cellular Therapy Service, Memorial Sloan Kettering Cancer Center
    11:00 AM PT (2:00 PM ET) - William Matsui
    • Hematologic Malignancy | Deputy Director, Livestrong Foundation Inc.
    12:00 PM PT (3:00 PM ET) - Justin Kaner
    • Leukemia, MDS, MPN | Assistant Professor of Clinical Medicine, Leukemia Program, Weill Cornell Medicine
    12:00 PM PT (3:00 PM ET) - Susanna Curtis
    • Sickle Cell | Assistant Director of the Sickle Cell Program, Icahn School of Medicine, Mount Sinai
    1:00 PM PT (4:00 PM ET) - Andrew Kuykendall
    • MPN (Myelofibrosis, PV, ET, SM) | Assistant Member in Malignant Hematology, Moffitt Cancer Center, USF Health
    1:00 PM PT (4:00 PM ET) - David Vesole
    • Multiple Myeloma | Director, Myeloma Program; Professor of Medicine, MedStar Georgetown University Hospital
    2:00 PM PT (5:00 PM ET) - Binod Dhakal
    • Multiple Myeloma | Associate Professor of Medicine, Medical College of Wisconsin
    2:00 PM PT (5:00 PM ET) - Thomas Leblanc
    • Leukemia, MDS, MPNs | Associate Professor of Medicine, Duke University School of Medicine, Duke Cancer Institute
    3:00 PM PT (6:00 PM ET) - Sunil Iyer
    • Leukemia, MDS, Myelofibrosis, PV, ET | Assistant Professor of Medicine, Columbia University Medical Center
    3:00 PM PT (6:00 PM ET) - Jeffrey Wolf
    • Multiple Myeloma | Staff Physician, The University of California, San Francisco
    Monday, December 9th
    9:00 AM PT (12:00 PM ET) - Douglas Tremblay
    • MPNs (Myelofibrosis, PV, ET), AML, CML | Physician and Assistant Professor of Hematology-Oncology, Icahn School of Medicine, Mount Sinai
    9:00 AM PT (12:00 PM ET) - Joshua Sasine
    • CAR T's | Assistant Professor of Medicine and Founder & Co-Director of the CAR-T Program, Cedars-Sinai Medical Center
    10:00 AM PT (1:00 PM ET) - Beverly Schaefer
    • Hemophilia | Assistant Professor of Oncology, Roswell Park Comprehensive Cancer Center
    10:00 AM PT (1:00 PM ET) - Elias Jabbour
    • AML, CML, ALL, MDS | Associate Professor, The University of Texas M. D. Anderson Cancer Center
    11:00 AM PT (2:00 PM ET) - Rory Shallis
    • Leukemia, MDS, MPN | Assistant Professor of Medicine in Hematology and Member of the Developmental Therapeutics Research Program, Yale University
    11:00 AM PT (2:00 PM ET) - Sherif Badawy
    • Non-Malignant Hematology | Founder and Chief Executive Officer, Dar Baklava
    12:00 PM PT (3:00 PM ET) - Marco Davila
    • CAR-T's | Vice Chair for Cellular Therapies, Roswell Park Cancer Institute
    12:00 PM PT (3:00 PM ET) - Ryan Jacobs
    • CLL, Lymphoma | Director of Lymphoma, Associate Professor, Levine Cancer Institute
    1:00 PM PT (4:00 PM ET) - Marco Ruella
    • Multiple Myeloma | Attending Physician, Scientific Director, Assistant Professor, University of Pennsylvania
    2:00 PM PT (5:00 PM ET) - Saurabh Dahiya
    • CAR-T's | Associate Professor of Medicine and Clinical Director of Cancer Cell Therapy, Stanford University School of Medicine

    *ASH Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.